← 產業報告目錄

Ultrasound Market by Technology (2D,3D,Doppler,CEU,HIFU, ESWL), Display (Colour, B/W), Portability (Trolly, Compact,POC), Component (Linear, Phased array, Workstation), Application (OB/GYN, Cardiology, Ortho), End User (Hospitals) Global Forecasts to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-01-22頁數 420報告編號 MD2885

授權報價

Single User Licence$7,150 USD
Multi User Licence$8,500 USD
Corporate User Licence$9,650 USD
Global User Licence$11,000 USD
洽詢購買 申請 Sample

報告摘要

The global ultrasound market is projected to reach USD 13.87 billion by 2030 from USD 9.32 billion in 2024, growing at a CAGR of 6.8% during the forecast period. The growth of the ultrasound market is driven by various key factors, including increasing prevalence rates of chronic diseases, such as cardiovascular conditions, cancer, and musculoskeletal disorders. These require sophisticated diagnostic equipment. Increasing demand for early diagnosis and non-invasive options also fuels adoption of the ultrasound technology. Advances in ultrasound itself, including AI integration, 3D/4D imaging, and portable equipment, make it more accessible and versatile in the clinical practice. “Diagnostic Ultrasound to register largest market share in 2023” Diagnostic ultrasound accounts for the largest share of the ultrasound market because it is capable of providing real-time, non-invasive imaging for a wide range of medical conditions. Its broad usage in obstetrics, cardiology, musculoskeletal imaging, and emergency care is contributing to its dominance. With this technology, it boasts such high accuracy, very low cost, and ionizing radiation-free; clinicians often turn to this for routine diagnostics. Improved ultrasound technology-3D/4D imaging, for instance, and AI-based tools have improved it so much that the use has remained on the growth track. “Hospitals segment held the largest share of ultrasound equipment market in 2023, by End-user.” Hospitals have the largest market share in this ultrasound industry due to its high volume of patients and diversified departments, along with the requirements of advanced imaging diagnostics within a wide spectrum of specializations. Obsterics, cardiology, emergency care, and musculoskeletal imaging are key applications within the hospital setup that have integrated ultrasound technology. The increased cases of chronic diseases and hospital emphasis on earlier diagnosis and treatment create high demand for ultrasound systems. More importantly, the advanced functionalities of ultrasound, such as real-time imaging, non-invasiveness, and increased accuracy, make it of more importance to hospitals, thereby becoming their main consumers of ultrasound technology. "Asia Pacific to register highest growth rate in the market during the forecast period." The Asia-Pacific region is reporting the highest growth rate in the ultrasound market, with factors such as an increasingly prevalent chronic disease population, an aged population, and a widening healthcare infrastructure base. Growth in demand for early and accurate diagnoses coupled with the affordability of ultrasound and its non-invasive nature has further increased adoption across the region. Additionally, growing government efforts to expand the healthcare market, increasing investments in health, diagnostic center expansions, and increase in hospital numbers are leading the rapid growth of this market in the Asia-Pacific region. Technology advancement and the greater availability of portable ultrasound equipment facilitate wider accessibility and adoption in Asia-Pacific. A number of drivers were responsible for the upswing, including: A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 40%, Tier 30%, and Tier 3 30% • By Designation: C-level-- 55%, Director-level–27%, and Others–18% • By Region: North America–35%, Europe-32%, Asia Pacific–25%, Latin America-6% , Middle East & Africa-2% Prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), Hologic Inc.(US), Samsung Electronics Co., Ltd (South Korea), Esaote SPA (Italy), Chison Medical Technologies Co., Ltd (China), MobiSante Inc (US), Clarius (Canada), MedGyn Products, Inc (US), Promed Technology (China), Neusoft Corporation (China) among others. Research Coverage The ultrasound equipment market has been segmented based on technology, display, component, portability, application, end-user, and region. Key factors for the growth of the market include driving forces, restraints, opportunities, and challenges among the stakeholders. The study also looks into the competition of the leading players within the market. The further division of the market can be seen in micro-markets to gain insight into the growth trends, prospects, and contributions to the overall market. It highlights future revenue growth prospects for various market segments across five major regions. Key Benefits of Buying the Report: The report would be useful for new market entrants in the ultrasound market as it gives detailed information about the market. This helps get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. This report segments the market precisely both by end-users and by regions for the purpose of attaining focused insights in the specific market segments. Additionally, it draws out the major trends, challenges, growth drivers, and opportunities to support the strategic decision-making process through adequate analysis. The report provides the insights on the following pointers: Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the ultrasound market. The rise of point-of-care diagnostics and expanding healthcare infrastructure further boosts market growth. Additionally, favorable reimbursement policies and the need for early detection support ultrasound adoption. Product Development/Innovation: The report includes emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for ultrasound market. Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the ultrasound market. Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the ultrasound market. Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), among others.
目錄 Table of Contents
1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 32 1.3 STUDY SCOPE 33 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 33 1.3.2 INCLUSIONS & EXCLUSIONS 34 1.4 YEARS CONSIDERED 35 1.5 CURRENCY CONSIDERED 35 1.6 MARKET STAKEHOLDERS 35 1.7 SUMMARY OF CHANGES 36 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH DATA 37 2.1.1 SECONDARY RESEARCH 38 2.1.1.1 Key data from secondary sources 40 2.1.2 PRIMARY RESEARCH 40 2.1.2.1 Key industry insights 41 2.2 MARKET SIZE ESTIMATION 42 2.2.1 BOTTOM-UP APPROACH 44 2.2.1.1 Approach 1: Company revenue estimation approach 44 2.2.1.2 Approach 2: Customer-based market estimation 45 2.2.1.3 Approach 3: Top-down approach 45 2.2.1.4 Approach 4: Primary interviews 46 2.3 DATA TRIANGULATION & MARKET BREAKDOWN 48 2.4 MARKET SHARE ASSESSMENT 49 2.5 STUDY ASSUMPTIONS 49 2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY 50 2.7 LIMITATIONS 50 2.8 RISK ASSESSMENT 50 3 EXECUTIVE SUMMARY 51 4 PREMIUM INSIGHTS 56 4.1 ULTRASOUND MARKET OVERVIEW 56 4.2 ULTRASOUND MARKET, BY REGION, 2022–2030 57 4.3 EUROPE: ULTRASOUND MARKET, BY REGION AND END USER, 2023 58 4.4 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET 59   5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 60 5.2.1 DRIVERS 61 5.2.1.1 Increasing prevalence of chronic diseases 61 5.2.1.2 Rising patient preference for minimally invasive surgeries 62 5.2.1.3 Rising technological advancements in ultrasound devices 62 5.2.1.4 Growing public and private investments, funding, and grants 63 5.2.2 RESTRAINTS 64 5.2.2.1 Unfavorable reimbursements 64 5.2.2.2 High operating costs 64 5.2.3 OPPORTUNITIES 65 5.2.3.1 Growing applications of therapeutic ultrasound 65 5.2.3.2 Growth in emerging markets 65 5.2.3.3 Development of POC ultrasound devices 66 5.2.4 CHALLENGES 67 5.2.4.1 Growing end-user preference for refurbished equipment 67 5.2.4.2 Shortage of skilled sonographers 67 5.3 INDUSTRY TRENDS 68 5.3.1 ENDOSCOPIC ULTRASOUND 68 5.3.2 WIRELESS AND PORTABLE SYSTEMS 68 5.4 VALUE CHAIN ANALYSIS 69 5.5 SUPPLY CHAIN ANALYSIS 70 5.5.1 PROMINENT COMPANIES 70 5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES 71 5.5.3 END USERS 71 5.6 PORTER’S FIVE FORCES ANALYSIS 72 5.6.1 THREAT OF NEW ENTRANTS 73 5.6.2 BARGAINING POWER OF SUPPLIERS 73 5.6.3 BARGAINING POWER OF BUYERS 73 5.6.4 THREAT OF SUBSTITUTES 73 5.6.5 INTENSITY OF COMPETITIVE RIVALRY 73 5.7 KEY STAKEHOLDERS & BUYING CRITERIA 74 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 74 5.7.2 BUYING CRITERIA 75 5.8 PATENT ANALYSIS 76 5.9 TRADE DATA ANALYSIS 78 5.9.1 IMPORT DATA 78 5.9.2 EXPORT DATA 79   5.10 KEY CONFERENCES & EVENTS, 2024–2025 79 5.11 UNMET NEEDS AND KEY PAIN POINTS 81 5.12 ECOSYSTEM ANALYSIS 81 5.13 IMPACT OF GEN AI ON ULTRASOUND MARKET 83 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84 5.15 TECHNOLOGY ANALYSIS 85 5.15.1 KEY TECHNOLOGIES 85 5.15.1.1 Contrast-enhanced ultrasound (CEUS) 85 5.15.1.2 Portable and handheld ultrasound devices 86 5.15.2 COMPLEMENTARY TECHNOLOGIES 86 5.15.2.1 Elastography 86 5.15.2.2 Fluoroscopy 86 5.15.3 ADJACENT TECHNOLOGIES 86 5.15.3.1 PET/CT 86 5.16 CASE STUDY ANALYSIS 87 5.16.1 LARGE-DIAMETER LUMEN-APPOSING METAL STENTS FOR WALLED-OFF NECROSIS 87 5.16.2 PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA CONGENITAL USING ULTRASONOGRAPHY 87 5.16.3 POSTOPERATIVE PERIRECTAL ABSCESS DRAINAGE 88 5.17 REGULATORY ANALYSIS 88 5.17.1 NORTH AMERICA 88 5.17.1.1 US 88 5.17.1.2 Canada 90 5.17.2 EUROPE 90 5.17.3 ASIA PACIFIC 91 5.17.3.1 Japan 91 5.17.3.2 China 92 5.17.3.3 India 93 5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 5.18 INVESTMENT & FUNDING SCENARIO 96 5.19 PRICING ANALYSIS 97 5.19.1 AVERAGE SELLING PRICE TREND, BY REGION 97 5.19.2 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER 101 5.20 REIMBURSEMENT SCENARIO 102 6 ULTRASOUND MARKET, BY TECHNOLOGY 103 6.1 INTRODUCTION 104 6.2 DIAGNOSTIC ULTRASOUND 104 6.2.1 2D ULTRASOUND 108 6.2.1.1 Growing demand for minimally invasive surgeries to increase use of 2D ultrasound 108   6.2.2 3D & 4D ULTRASOUND 111 6.2.2.1 Improved diagnosis with 3D ultrasound technology to boost market growth 111 6.2.3 DOPPLER ULTRASOUND 114 6.2.3.1 Growing applications in cardiology and vascular to drive market growth 114 6.2.4 CONTRAST-ENHANCED ULTRASOUND 117 6.2.4.1 Enhanced diagnostic imaging with advanced ultrasound systems to boost demand 117 6.3 THERAPEUTIC ULTRASOUND 120 6.3.1 HIGH-INTENSITY-FOCUSED ULTRASOUND 124 6.3.1.1 Advancing cancer treatment with HIFU to fuel growth 124 6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY 128 6.3.2.1 Enhancing urolithiasis treatment with advanced ESWL techniques and technologies to propel market 128 7 ULTRASOUND MARKET, BY DISPLAY 132 7.1 INTRODUCTION 133 7.2 COLOR ULTRASOUND 134 7.2.1 GROWING DEMAND FOR COLOR ULTRASOUND TO SUPPORT MARKET GROWTH 134 7.3 BLACK & WHITE ULTRASOUND 137 7.3.1 ENHANCED DIAGNOSTIC PRECISION WITH B/W ULTRASOUND TO DRIVE DEMAND 137 8 ULTRASOUND MARKET, BY PORTABILITY 142 8.1 INTRODUCTION 143 8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS 144 8.2.1 IMPROVED PATIENT EXPERIENCE WITH TROLLEY-BASED ULTRASOUND SYSTEMS TO DRIVE MARKET GROWTH 144 8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS 148 8.3.1 GROWING NUMBER OF TRAUMA/EMERGENCY CASES TO FUEL MARKET GROWTH 148 8.4 POC ULTRASOUND DEVICES 152 8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND FOR POC ULTRASOUND DEVICES 152 9 ULTRASOUND MARKET, BY APPLICATION 156 9.1 INTRODUCTION 157 9.2 RADIOLOGY/GENERAL IMAGING 157 9.2.1 GROWING NUMBER OF CHRONIC DISEASES LEADING TO INCREASED USE OF THIS APPLICATION 157 9.3 CARDIOLOGY 160 9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASE ACROSS MAJOR HEALTHCARE MARKETS TO DRIVE GROWTH 160 9.4 OB/GYN 163 9.4.1 WIDE ADOPTION OF AI IN ULTRASOUND IN FIELD OF OB/GYN TO BOOST MARKET 163   9.5 UROLOGY 167 9.5.1 WIDE USE OF ULTRASOUND IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO DRIVE MARKET 167 9.6 VASCULAR 170 9.6.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 170 9.7 ORTHOPEDIC & MUSCULOSKELETAL 174 9.7.1 RISING PREVALENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH 174 9.8 PAIN MANAGEMENT 177 9.8.1 GROWING ADOPTION OF PORTABLE ULTRASOUND FOR PAIN MANAGEMENT TO SUPPORT GROWTH 177 9.9 PEDIATRIC 180 9.9.1 GROWING USE OF PEDIATRIC ULTRASOUND TO COMBAT NEONATAL MORTALITY TO SPUR GROWTH 180 9.10 OTHER APPLICATIONS 184 10 ULTRASOUND MARKET, BY COMPONENT 188 10.1 INTRODUCTION 189 10.2 TRANSDUCERS/PROBES 190 10.2.1 CURVILINEAR/CONVEX ARRAY PROBES 194 10.2.1.1 Enhanced diagnosis with curvilinear and convex array ultrasound probes to boost market 194 10.2.2 LINEAR ARRAY PROBES 195 10.2.2.1 High-resolution power with linear array ultrasound systems to drive demand 195 10.2.3 PHASED ARRAY PROBES 196 10.2.3.1 Advanced imaging capabilities to drive market growth 196 10.2.4 OTHER PROBES 197 10.3 WORKSTATIONS 197 10.3.1 INCREASE IN DIAGNOSTIC PROCEDURES TO PROPEL DEMAND FOR WORKSTATIONS 197 10.4 OTHER COMPONENTS 201 11 ULTRASOUND MARKET, BY END USER 204 11.1 INTRODUCTION 205 11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS 205 11.2.1 INCREASING PREVALENCE OF CANCER TO BOOST MARKET GROWTH 205 11.3 MATERNITY CENTERS 207 11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND SYSTEMS FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH 207 11.4 AMBULATORY CENTERS 208 11.4.1 INCREASING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH 208 11.5 RESEARCH & ACADEMIC INSTITUTES 209 11.5.1 GROWING NUMBER OF RESEARCH GRANTS TO BOOST MARKET GROWTH 209 11.6 OTHER END USERS 210 12 ULTRASOUND MARKET, BY REGION 212 12.1 INTRODUCTION 213 12.2 EUROPE 214 12.2.1 MACROECONOMIC OUTLOOK FOR EUROPE 214 12.2.2 GERMANY 220 12.2.2.1 Growing healthcare expenditures and grants to drive market 220 12.2.3 FRANCE 224 12.2.3.1 Increasing population and rising number of centers to drive market 224 12.2.4 UK 227 12.2.4.1 Increasing prevalence of chronic diseases to contribute to market growth 227 12.2.5 ITALY 231 12.2.5.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market 231 12.2.6 SPAIN 234 12.2.6.1 Growing focus on cancer research to support market growth 234 12.2.7 REST OF EUROPE 238 12.3 NORTH AMERICA 241 12.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 241 12.3.2 US 246 12.3.2.1 Rise in cancer prevalence to drive market 246 12.3.3 CANADA 254 12.3.3.1 New product launches & conferences to drive market 254 12.4 ASIA PACIFIC 258 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 258 12.4.2 CHINA 264 12.4.2.1 Increasing acquisitions and partnerships to drive market 264 12.4.3 JAPAN 268 12.4.3.1 Established healthcare infrastructure and research facilities to drive market 268 12.4.4 INDIA 272 12.4.4.1 Government initiatives to drive market 272 12.4.5 AUSTRALIA 275 12.4.5.1 Growing healthcare spending and increasing investments in research to drive market 275 12.4.6 SOUTH KOREA 279 12.4.6.1 Well-developed healthcare system and conferences to drive market 279 12.4.7 REST OF ASIA PACIFIC 283 12.5 LATIN AMERICA 287 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 287 12.5.2 BRAZIL 292 12.5.2.1 Greater purchasing power and favorable demographic conditions to drive market 292   12.5.3 MEXICO 295 12.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 295 12.5.4 REST OF LATIN AMERICA 298 12.6 MIDDLE EAST & AFRICA 302 12.6.1 GROWING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET 302 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302 12.6.3 GCC COUNTRIES 307 12.6.3.1 Developments in investment approach to drive market 307 12.6.4 REST OF MIDDLE EAST & AFRICA 310 13 COMPETITIVE LANDSCAPE 314 13.1 INTRODUCTION 314 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 314 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET 315 13.3 REVENUE ANALYSIS, 2019–2023 316 13.4 MARKET SHARE ANALYSIS, 2023 317 13.4.1 RANKING OF KEY MARKET PLAYERS 319 13.5 COMPANY EVALUATION MATRIX: DIAGNOSTIC ULTRASOUND MARKET (KEY PLAYERS), 2023 319 13.5.1 STARS 319 13.5.2 EMERGING LEADERS 319 13.5.3 PERVASIVE PLAYERS 319 13.5.4 PARTICIPANTS 320 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 321 13.5.5.1 Company footprint 321 13.5.5.2 Region footprint 322 13.5.5.3 Technology footprint 323 13.5.5.4 Display footprint 324 13.5.5.5 Portability footprint 325 13.5.5.6 Component footprint 326 13.5.5.7 Application footprint 327 13.5.5.8 End-user footprint 328 13.6 COMPANY EVALUATION MATRIX: THERAPEUTIC ULTRASOUND MARKET (STARTUPS/SMES), 2023 329 13.6.1 PROGRESSIVE COMPANIES 329 13.6.2 RESPONSIVE COMPANIES 329 13.6.3 DYNAMIC COMPANIES 329 13.6.4 STARTING BLOCKS 329 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 331 13.7 COMPANY VALUATION & FINANCIAL METRICS 332 13.7.1 FINANCIAL METRICS 332 13.7.2 COMPANY VALUATION 332   13.8 BRAND/PRODUCT COMPARISON 333 13.9 COMPETITIVE SCENARIO 334 13.9.1 PRODUCT LAUNCHES & APPROVALS 334 13.9.2 DEALS 335 14 COMPANY PROFILES 336 14.1 KEY PLAYERS 336 14.1.1 GE HEALTHCARE 336 14.1.1.1 Business overview 336 14.1.1.2 Products offered 337 14.1.1.3 Recent developments 339 14.1.1.3.1 Product launches, approvals, and upgrades 339 14.1.1.3.2 Deals 341 14.1.1.3.3 Other developments 342 14.1.1.4 MnM view 342 14.1.1.4.1 Right to win 342 14.1.1.4.2 Strategic choices 342 14.1.1.4.3 Weaknesses & competitive threats 342 14.1.2 PHILIPS HEALTHCARE 343 14.1.2.1 Business overview 343 14.1.2.2 Products offered 344 14.1.2.3 Recent developments 346 14.1.2.3.1 Product launches & approvals 346 14.1.2.3.2 Deals 346 14.1.2.4 MnM view 347 14.1.2.4.1 Right to win 347 14.1.2.4.2 Strategic choices 347 14.1.2.4.3 Weaknesses & competitive threats 347 14.1.3 CANON MEDICAL SYSTEMS CORPORATION 348 14.1.3.1 Business overview 348 14.1.3.2 Products offered 350 14.1.3.3 Recent developments 351 14.1.3.3.1 Product launches 351 14.1.3.3.2 Deals 351 14.1.3.3.3 Expansions 351 14.1.3.4 MnM view 352 14.1.3.4.1 Right to win 352 14.1.3.4.2 Strategic choices 352 14.1.3.4.3 Weaknesses & competitive threats 352   14.1.4 SIEMENS HEALTHINEERS AG 353 14.1.4.1 Business overview 353 14.1.4.2 Products offered 355 14.1.4.3 Recent developments 355 14.1.4.3.1 Product launches 355 14.1.4.3.2 Deals 356 14.1.4.3.3 Expansions 356 14.1.4.4 MnM view 356 14.1.4.4.1 Right to win 356 14.1.4.4.2 Strategic choices 356 14.1.4.4.3 Weaknesses & competitive threats 357 14.1.5 FUJIFILM CORPORATION 358 14.1.5.1 Business overview 358 14.1.5.2 Products offered 359 14.1.5.3 Recent developments 361 14.1.5.3.1 Product launches 361 14.1.5.3.2 Deals 361 14.1.5.3.3 Expansions 362 14.1.5.4 MnM view 362 14.1.5.4.1 Right to win 362 14.1.5.4.2 Strategic choices 362 14.1.5.4.3 Weaknesses & competitive threats 362 14.1.6 HOLOGIC, INC. 363 14.1.6.1 Business overview 363 14.1.6.2 Products offered 365 14.1.6.3 Recent developments 366 14.1.6.3.1 Product launches 366 14.1.6.3.2 Deals 367 14.1.6.3.3 Expansions 367 14.1.7 SAMSUNG ELECTRONICS CO., LTD. 368 14.1.7.1 Business overview 368 14.1.7.2 Products offered 369 14.1.7.3 Recent developments 371 14.1.7.3.1 Product launches 371 14.1.7.3.2 Deals 372 14.1.7.3.3 Other developments 372 14.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 373 14.1.8.1 Business overview 373 14.1.8.2 Products offered 374 14.1.8.3 Recent developments 376 14.1.8.3.1 Product launches 376 14.1.8.3.2 Deals 377 14.1.9 ESAOTE SPA 378 14.1.9.1 Business overview 378 14.1.9.2 Products offered 379 14.1.9.3 Recent developments 381 14.1.9.3.1 Product launches 381 14.1.9.3.2 Deals 381 14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD. 382 14.1.10.1 Business overview 382 14.1.10.2 Products offered 383 14.1.10.3 Recent developments 384 14.1.10.3.1 Product launches 384 14.1.10.3.2 Deals 384 14.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD. 385 14.1.11.1 Business overview 385 14.1.11.2 Products offered 386 14.1.11.3 Recent developments 387 14.1.11.3.1 Product launches 387 14.1.12 KONICA MINOLTA, INC 388 14.1.12.1 Business overview 388 14.1.12.2 Products offered 389 14.1.13 CLARIUS 390 14.1.13.1 Business overview 390 14.1.13.2 Products offered 390 14.1.13.3 Recent developments 391 14.1.13.3.1 Product launches 391 14.1.13.3.2 Deals 392 14.1.14 MEDGYN PRODUCTS, INC. 393 14.1.14.1 Business overview 393 14.1.14.2 Products offered 393 14.1.15 PROMED TECHNOLOGY CO., LTD. 394 14.1.15.1 Business overview 394 14.1.15.2 Products offered 394 14.2 OTHER COMPANIES 396 14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC. 396 14.2.2 SHENZHEN RICSO TECHNOLOGY CO., LTD. 397 14.2.3 YOUKEY MEDICAL 398 14.2.4 SIUI 399 14.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING 400 14.2.6 BUTTERFLY NETWORK, INC. 401 14.2.7 ALPINION MEDICAL SYSTEMS 402 14.2.8 EDAN INSTRUMENTS, INC. 403 14.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD. 404 14.2.10 ECHONOUS INC. 405 14.2.11 MOBISANTE, INC. 406 14.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD. 407 14.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD. 408 14.2.14 SONOSCAPE MEDICAL CORP. 408 14.2.15 CURA HEALTHCARE 410 15 APPENDIX 411 15.1 DISCUSSION GUIDE 411 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 416 15.3 CUSTOMIZATION OPTIONS 418 15.4 RELATED REPORTS 418 15.5 AUTHOR DETAILS 419
圖表清單 List of Tables & Figures
TABLE 1 ULTRASOUND MARKET: INCLUSIONS & EXCLUSIONS 34 TABLE 2 LIMITATIONS AND ASSOCIATED RISKS 50 TABLE 3 RECENT PRODUCT LAUNCHES IN ULTRASOUND MARKET 63 TABLE 4 COMPARISON BETWEEN AVERAGE SELLING PRICE OF ULTRASOUND AND REFURBISHED MEDICAL EQUIPMENT 67 TABLE 5 ULTRASOUND MARKET: IMPACT OF PORTER’S FIVE FORCES 72 TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 74 TABLE 7 KEY BUYING CRITERIA, BY END USER 75 TABLE 8 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024 77 TABLE 9 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2023 (USD THOUSAND) 78 TABLE 10 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2023 (USD THOUSAND) 79 TABLE 11 ULTRASOUND MARKET: KEY CONFERENCES & EVENTS, 2024–2025 79 TABLE 12 ULTRASOUND MARKET: CURRENT UNMET NEEDS 81 TABLE 13 ULTRASOUND MARKET: ROLE OF COMPANIES IN ECOSYSTEM 82 TABLE 14 US FDA: MEDICAL DEVICE CLASSIFICATION 89 TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 89 TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90 TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 91 TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 92 TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 24 AVERAGE SELLING PRICE OF ULTRASOUND, BY REGION, 2021–2023 (USD THOUSAND) 99 TABLE 25 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD) 101 TABLE 26 US: MAJOR CPT CODES FOR ULTRASOUND, 2023 102 TABLE 27 ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 104 TABLE 28 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 105 TABLE 29 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 105 TABLE 30 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 106 TABLE 31 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 106 TABLE 32 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107 TABLE 33 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107 TABLE 34 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 108 TABLE 35 2D ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 109 TABLE 36 NORTH AMERICA: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109 TABLE 37 EUROPE: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 110 TABLE 38 ASIA PACIFIC: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 110 TABLE 39 LATIN AMERICA: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111 TABLE 40 MIDDLE EAST & AFRICA: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111 TABLE 41 3D & 4D ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 112 TABLE 42 NORTH AMERICA: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 112 TABLE 43 EUROPE: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113 TABLE 44 ASIA PACIFIC: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113 TABLE 45 LATIN AMERICA: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 114 TABLE 46 MIDDLE EAST & AFRICA: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 114 TABLE 47 DOPPLER ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 115 TABLE 48 NORTH AMERICA: DOPPLER ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 115 TABLE 49 EUROPE: DOPPLER ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 50 ASIA PACIFIC: DOPPLER ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 51 LATIN AMERICA: DOPPLER ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 117 TABLE 52 MIDDLE EAST & AFRICA: DOPPLER ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 117 TABLE 53 CONTRAST-ENHANCED ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 118 TABLE 54 NORTH AMERICA: CONTRAST-ENHANCED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 118 TABLE 55 EUROPE: CONTRAST-ENHANCED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 119 TABLE 56 ASIA PACIFIC: CONTRAST-ENHANCED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 119 TABLE 57 LATIN AMERICA: CONTRAST-ENHANCED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 120 TABLE 58 MIDDLE EAST & AFRICA: CONTRAST-ENHANCED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 120 TABLE 59 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 121 TABLE 60 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 121 TABLE 61 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 122 TABLE 62 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 122 TABLE 63 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 123 TABLE 64 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 123 TABLE 65 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 124 TABLE 66 HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 125 TABLE 67 NORTH AMERICA: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 125 TABLE 68 EUROPE: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 126 TABLE 69 ASIA PACIFIC: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 126 TABLE 70 LATIN AMERICA: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 127 TABLE 71 MIDDLE EAST & AFRICA: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 127 TABLE 72 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY REGION, 2022–2030 (USD MILLION) 128 TABLE 73 NORTH AMERICA: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 129 TABLE 74 EUROPE: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 129 TABLE 75 ASIA PACIFIC: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 130 TABLE 76 LATIN AMERICA: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 130 TABLE 77 MIDDLE EAST & AFRICA: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 131 TABLE 78 ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 133 TABLE 79 ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (UNITS) 133 TABLE 80 COLOR ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 134 TABLE 81 COLOR ULTRASOUND MARKET, BY REGION, 2022–2030 (UNITS) 135 TABLE 82 NORTH AMERICA: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 135 TABLE 83 EUROPE: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 136 TABLE 84 ASIA PACIFIC: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 136 TABLE 85 LATIN AMERICA: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 137 TABLE 86 MIDDLE EAST & AFRICA: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 137 TABLE 87 BLACK & WHITE ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 138 TABLE 88 BLACK & WHITE ULTRASOUND MARKET, BY REGION, 2022–2030 (UNITS) 138 TABLE 89 NORTH AMERICA: BLACK & WHITE ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 139 TABLE 90 EUROPE: BLACK & WHITE ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 139 TABLE 91 ASIA PACIFIC: BLACK & WHITE ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 140 TABLE 92 LATIN AMERICA: BLACK & WHITE ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 140 TABLE 93 MIDDLE EAST & AFRICA: BLACK & WHITE ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 141 TABLE 94 ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 143 TABLE 95 ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (UNITS) 143 TABLE 96 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION) 144 TABLE 97 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (UNITS) 145 TABLE 98 NORTH AMERICA: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 145 TABLE 99 EUROPE: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 146 TABLE 100 ASIA PACIFIC: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 146 TABLE 101 LATIN AMERICA: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 147 TABLE 102 MIDDLE EAST & AFRICA: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 147 TABLE 103 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION) 148 TABLE 104 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (UNITS) 149 TABLE 105 NORTH AMERICA: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 149 TABLE 106 EUROPE: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 150 TABLE 107 ASIA PACIFIC: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 150 TABLE 108 LATIN AMERICA: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 151 TABLE 109 MIDDLE EAST & AFRICA: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 151 TABLE 110 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION) 152 TABLE 111 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (UNITS) 153 TABLE 112 NORTH AMERICA: POC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 153 TABLE 113 EUROPE: POC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 154 TABLE 114 ASIA PACIFIC: POC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 154 TABLE 115 LATIN AMERICA: POC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 155 TABLE 116 MIDDLE EAST & AFRICA: POC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 155 TABLE 117 ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 157 TABLE 118 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 158 TABLE 119 NORTH AMERICA: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 158 TABLE 120 EUROPE: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 159 TABLE 121 ASIA PACIFIC: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 159 TABLE 122 LATIN AMERICA: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 160 TABLE 123 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 160 TABLE 124 ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 161 TABLE 125 NORTH AMERICA: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 161 TABLE 126 EUROPE: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 162 TABLE 127 ASIA PACIFIC: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 162 TABLE 128 LATIN AMERICA: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 163 TABLE 129 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 163 TABLE 130 ULTRASOUND MARKET FOR OB/GYN APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 164 TABLE 131 NORTH AMERICA: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 165 TABLE 132 EUROPE: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 165 TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 166 TABLE 134 LATIN AMERICA: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 166 TABLE 135 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 167 TABLE 136 ULTRASOUND MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 168 TABLE 137 NORTH AMERICA: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 168 TABLE 138 EUROPE: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 169 TABLE 139 ASIA PACIFIC: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 169 TABLE 140 LATIN AMERICA: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 170 TABLE 141 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 170 TABLE 142 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 171 TABLE 143 NORTH AMERICA: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 171 TABLE 144 EUROPE: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 172 TABLE 145 ASIA PACIFIC: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 172 TABLE 146 LATIN AMERICA: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 173 TABLE 147 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 173 TABLE 148 ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 174 TABLE 149 NORTH AMERICA: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 175 TABLE 150 EUROPE: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 175 TABLE 151 ASIA PACIFIC: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 176 TABLE 152 LATIN AMERICA: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 176 TABLE 153 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 177 TABLE 154 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 178 TABLE 155 NORTH AMERICA: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 178 TABLE 156 EUROPE: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 179 TABLE 157 ASIA PACIFIC: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 179 TABLE 158 LATIN AMERICA: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 180 TABLE 159 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 180 TABLE 160 GLOBAL MORTALITY RATE OF NEONATES, CHILDREN, AND ADOLESCENTS IN 2022 181 TABLE 161 ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 181 TABLE 162 NORTH AMERICA: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 182 TABLE 163 EUROPE: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 182 TABLE 164 ASIA PACIFIC: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 183 TABLE 165 LATIN AMERICA: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 183 TABLE 166 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 184 TABLE 167 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 184 TABLE 168 NORTH AMERICA: ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 185 TABLE 169 EUROPE: ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 185 TABLE 170 ASIA PACIFIC: ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 186 TABLE 171 LATIN AMERICA: ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 186 TABLE 172 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 187 TABLE 173 ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 189 TABLE 174 ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2022–2030 (USD MILLION) 190 TABLE 175 ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY REGION, 2022–2030 (USD MILLION) 191 TABLE 176 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY COUNTRY, 2022–2030 (USD MILLION) 191 TABLE 177 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY COUNTRY, 2022–2030 (USD MILLION) 192 TABLE 178 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY COUNTRY, 2022–2030 (USD MILLION) 192 TABLE 179 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY COUNTRY, 2022–2030 (USD MILLION) 193 TABLE 180 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY COUNTRY, 2022–2030 (USD MILLION) 193 TABLE 181 ULTRASOUND MARKET FOR CURVILINEAR/CONVEX ARRAY PROBES, BY REGION, 2022–2030 (USD MILLION) 194 TABLE 182 ULTRASOUND MARKET FOR LINEAR ARRAY PROBES, BY REGION, 2022–2030 (USD MILLION) 195 TABLE 183 ULTRASOUND MARKET FOR PHASED ARRAY PROBES, BY REGION, 2022–2030 (USD MILLION) 196 TABLE 184 ULTRASOUND MARKET FOR OTHER PROBES, BY REGION, 2022–2030 (USD MILLION) 197 TABLE 185 ULTRASOUND MARKET FOR WORKSTATIONS, BY REGION, 2022–2030 (USD MILLION) 198 TABLE 186 NORTH AMERICA: ULTRASOUND MARKET FOR WORKSTATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 198 TABLE 187 EUROPE: ULTRASOUND MARKET FOR WORKSTATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 199 TABLE 188 ASIA PACIFIC: ULTRASOUND MARKET FOR WORKSTATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 199 TABLE 189 LATIN AMERICA: ULTRASOUND MARKET FOR WORKSTATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 200 TABLE 190 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR WORKSTATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 200 TABLE 191 ULTRASOUND MARKET FOR OTHER COMPONENTS, BY REGION, 2022–2030 (USD MILLION) 201 TABLE 192 NORTH AMERICA: ULTRASOUND MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2022–2030 (USD MILLION) 201 TABLE 193 EUROPE: ULTRASOUND MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2022–2030 (USD MILLION) 202 TABLE 194 ASIA PACIFIC: ULTRASOUND MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2022–2030 (USD MILLION) 202 TABLE 195 LATIN AMERICA: ULTRASOUND MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2022–2030 (USD MILLION) 203 TABLE 196 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2022–2030 (USD MILLION) 203 TABLE 197 ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 205 TABLE 198 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2022–2030 (USD MILLION) 206 TABLE 199 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 2022–2030 (USD MILLION) 207 TABLE 200 ULTRASOUND MARKET FOR AMBULATORY CENTERS, BY REGION, 2022–2030 (USD MILLION) 209 TABLE 201 ULTRASOUND MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2030 (USD MILLION) 210 TABLE 202 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 211 TABLE 203 ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 213 TABLE 204 EUROPE: MACROECONOMIC OUTLOOK 214 TABLE 205 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 216 TABLE 206 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 216 TABLE 207 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 217 TABLE 208 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 217 TABLE 209 EUROPE: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 217 TABLE 210 EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 218 TABLE 211 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 218 TABLE 212 EUROPE: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 219 TABLE 213 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2022–2030 (USD MILLION) 219 TABLE 214 EUROPE: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 220 TABLE 215 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 221 TABLE 216 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 221 TABLE 217 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 222 TABLE 218 GERMANY: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 222 TABLE 219 GERMANY: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 222 TABLE 220 GERMANY: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 223 TABLE 221 GERMANY: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 223 TABLE 222 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 224 TABLE 223 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 225 TABLE 224 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 225 TABLE 225 FRANCE: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 225 TABLE 226 FRANCE: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 226 TABLE 227 FRANCE: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 226 TABLE 228 FRANCE: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 227 TABLE 229 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 228 TABLE 230 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 228 TABLE 231 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 228 TABLE 232 UK: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 229 TABLE 233 UK: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 229 TABLE 234 UK: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 230 TABLE 235 UK: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 230 TABLE 236 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 231 TABLE 237 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 232 TABLE 238 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 232 TABLE 239 ITALY: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 232 TABLE 240 ITALY: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 233 TABLE 241 ITALY: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 233 TABLE 242 ITALY: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 234 TABLE 243 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 235 TABLE 244 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 235 TABLE 245 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 236 TABLE 246 SPAIN: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 236 TABLE 247 SPAIN: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 236 TABLE 248 SPAIN: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 237 TABLE 249 SPAIN: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 237 TABLE 250 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 238 TABLE 251 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 239 TABLE 252 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 239 TABLE 253 REST OF EUROPE: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 239 TABLE 254 REST OF EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 240 TABLE 255 REST OF EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 240 TABLE 256 REST OF EUROPE: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 241 TABLE 257 NORTH AMERICA: MACROECONOMIC OUTLOOK 242 TABLE 258 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 242 TABLE 259 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 242 TABLE 260 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 243 TABLE 261 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 243 TABLE 262 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 243 TABLE 263 NORTH AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 244 TABLE 264 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 244 TABLE 265 NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 245 TABLE 266 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2022–2030 (USD MILLION) 245 TABLE 267 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 246 TABLE 268 POCUS ULTRASOUND CPT CODES (2021) 247 TABLE 269 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 251 TABLE 270 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 251 TABLE 271 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 252 TABLE 272 US: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 252 TABLE 273 US: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 252 TABLE 274 US: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 253 TABLE 275 US: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 253 TABLE 276 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 255 TABLE 277 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 255 TABLE 278 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 255 TABLE 279 CANADA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 256 TABLE 280 CANADA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 256 TABLE 281 CANADA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 257 TABLE 282 CANADA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 257 TABLE 283 ASIA PACIFIC: MACROECONOMIC INDICATORS 258 TABLE 284 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 260 TABLE 285 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 260 TABLE 286 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 261 TABLE 287 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 261 TABLE 288 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 261 TABLE 289 ASIA PACIFIC: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 262 TABLE 290 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 262 TABLE 291 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 263 TABLE 292 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2022–2030 (USD MILLION) 263 TABLE 293 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 264 TABLE 294 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 265 TABLE 295 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 265 TABLE 296 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 266 TABLE 297 CHINA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 266 TABLE 298 CHINA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 266 TABLE 299 CHINA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 267 TABLE 300 CHINA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 267 TABLE 301 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 269 TABLE 302 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 269 TABLE 303 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 269 TABLE 304 JAPAN: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 270 TABLE 305 JAPAN: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 270 TABLE 306 JAPAN: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 271 TABLE 307 JAPAN: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 271 TABLE 308 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 272 TABLE 309 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 273 TABLE 310 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 273 TABLE 311 INDIA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 273 TABLE 312 INDIA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 274 TABLE 313 INDIA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 274 TABLE 314 INDIA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 275 TABLE 315 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 276 TABLE 316 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 276 TABLE 317 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 276 TABLE 318 AUSTRALIA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 277 TABLE 319 AUSTRALIA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 277 TABLE 320 AUSTRALIA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 278 TABLE 321 AUSTRALIA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 278 TABLE 322 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 280 TABLE 323 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 280   TABLE 324 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 280 TABLE 325 SOUTH KOREA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 281 TABLE 326 SOUTH KOREA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 281 TABLE 327 SOUTH KOREA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 282 TABLE 328 SOUTH KOREA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 282 TABLE 329 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 283 TABLE 330 REST OF ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 284 TABLE 331 REST OF ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 284 TABLE 332 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 285 TABLE 333 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 285 TABLE 334 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 286 TABLE 335 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 286 TABLE 336 LATIN AMERICA: MACROECONOMIC OUTLOOK 287 TABLE 337 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 288 TABLE 338 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 288 TABLE 339 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 288 TABLE 340 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 289 TABLE 341 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 289 TABLE 342 LATIN AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 289 TABLE 343 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 290 TABLE 344 LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 290 TABLE 345 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2022–2030 (USD MILLION) 291 TABLE 346 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 291 TABLE 347 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 292 TABLE 348 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 292 TABLE 349 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 293 TABLE 350 BRAZIL: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 293 TABLE 351 BRAZIL: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 293 TABLE 352 BRAZIL: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 294 TABLE 353 BRAZIL: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 294 TABLE 354 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 295 TABLE 355 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 296 TABLE 356 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 296 TABLE 357 MEXICO: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 296 TABLE 358 MEXICO: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 297   TABLE 359 MEXICO: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 297 TABLE 360 MEXICO: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 298 TABLE 361 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 298 TABLE 362 REST OF LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 299 TABLE 363 REST OF LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 299 TABLE 364 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 300 TABLE 365 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 300 TABLE 366 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 301 TABLE 367 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 301 TABLE 368 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 302 TABLE 369 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 303 TABLE 370 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 303 TABLE 371 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 303 TABLE 372 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 304 TABLE 373 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 304 TABLE 374 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 304 TABLE 375 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 305 TABLE 376 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 305 TABLE 377 MIDDLE EAST & AFRICA: TRANSDUCERS/PROBES MARKET, BY TYPE, 2022–2030 (USD MILLION) 306 TABLE 378 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 306 TABLE 379 GCC COUNTRIES: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 307 TABLE 380 GCC COUNTRIES: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 307 TABLE 381 GCC COUNTRIES: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 308 TABLE 382 GCC COUNTRIES: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 308 TABLE 383 GCC COUNTRIES: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 308 TABLE 384 GCC COUNTRIES: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 309 TABLE 385 GCC COUNTRIES: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 309 TABLE 386 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 310   TABLE 387 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 310 TABLE 388 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 311 TABLE 389 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 311 TABLE 390 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 312 TABLE 391 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 312 TABLE 392 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 313 TABLE 393 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ULTRASOUND MARKET 315 TABLE 394 ULTRASOUND MARKET: DEGREE OF COMPETITION 318 TABLE 395 ULTRASOUND MARKET: REGION FOOTPRINT 322 TABLE 396 ULTRASOUND MARKET: TECHNOLOGY FOOTPRINT 323 TABLE 397 ULTRASOUND MARKET: DISPLAY FOOTPRINT 324 TABLE 398 ULTRASOUND MARKET: PORTABILITY FOOTPRINT 325 TABLE 399 ULTRASOUND MARKET: COMPONENT FOOTPRINT 326 TABLE 400 ULTRASOUND MARKET: APPLICATION FOOTPRINT 327 TABLE 401 ULTRASOUND MARKET: END-USER FOOTPRINT 328 TABLE 402 ULTRASOUND EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 331 TABLE 403 ULTRASOUND MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024 334 TABLE 404 ULTRASOUND MARKET: DEALS, JANUARY 2021–NOVEMBER 2024 335 TABLE 405 GE HEALTHCARE: COMPANY OVERVIEW 336 TABLE 406 GE HEALTHCARE: PRODUCTS OFFERED 337 TABLE 407 GE HEALTHCARE: PRODUCT LAUNCHES, APPROVALS, AND UPGRADES, JANUARY 2021–NOVEMBER 2024 339 TABLE 408 GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 341 TABLE 409 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 342 TABLE 410 PHILIPS HEALTHCARE: COMPANY OVERVIEW 343 TABLE 411 PHILIPS HEALTHCARE: PRODUCTS OFFERED 344 TABLE 412 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024 346 TABLE 413 PHILIPS HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 346 TABLE 414 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 348 TABLE 415 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 350 TABLE 416 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 351 TABLE 417 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 351 TABLE 418 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 351   TABLE 419 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 353 TABLE 420 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 355 TABLE 421 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024 355 TABLE 422 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024 356 TABLE 423 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 356 TABLE 424 FUJIFILM CORPORATION: COMPANY OVERVIEW 358 TABLE 425 FUJIFILM CORPORATION: PRODUCTS OFFERED 359 TABLE 426 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 361 TABLE 427 FUJIFILM CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 361 TABLE 428 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 362 TABLE 429 HOLOGIC, INC.: COMPANY OVERVIEW 363 TABLE 430 HOLOGIC, INC.: PRODUCTS OFFERED 365 TABLE 431 HOLOGIC, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 366 TABLE 432 HOLOGIC, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 367 TABLE 433 HOLOGIC, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 367 TABLE 434 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW 368 TABLE 435 SAMSUNG ELECTRONICS CO., LTD.: PRODUCTS OFFERED 369 TABLE 436 SAMSUNG ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 371 TABLE 437 SAMSUNG ELECTRONICS CO., LTD.: DEALS, JANUARY 2021–MARCH 2024 372 TABLE 438 SAMSUNG ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024 372 TABLE 439 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY OVERVIEW 373 TABLE 440 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCTS OFFERED 374 TABLE 441 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 376 TABLE 442 MINDRAY MEDICAL INTERNATIONAL LIMITED: DEALS, JANUARY 2021–NOVEMBER 2024 377 TABLE 443 ESAOTE SPA: COMPANY OVERVIEW 378 TABLE 444 ESAOTE SPA: PRODUCTS OFFERED 379 TABLE 445 ESAOTE SPA: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 381 TABLE 446 ESAOTE SPA: DEALS, JANUARY 2021–NOVEMBER 2024 381 TABLE 447 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 382 TABLE 448 CHISON MEDICAL TECHNOLOGIES CO., LTD.: PRODUCTS OFFERED 383 TABLE 449 CHISON MEDICAL TECHNOLOGIES CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 384 TABLE 450 CHISON MEDICAL TECHNOLOGIES CO., LTD.: DEALS, JANUARY 2021–NOVEMBER 2024 384 TABLE 451 NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 385 TABLE 452 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 386 TABLE 453 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 387 TABLE 454 KONICA MINOLTA, INC.: COMPANY OVERVIEW 388 TABLE 455 KONICA MINOLTA, INC.: PRODUCTS OFFERED 389   TABLE 456 CLARIUS: COMPANY OVERVIEW 390 TABLE 457 CLARIUS: PRODUCTS OFFERED 390 TABLE 458 CLARIUS: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 391 TABLE 459 CLARIUS: DEALS, JANUARY 2021–NOVEMBER 2024 392 TABLE 460 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW 393 TABLE 461 MEDGYN PRODUCTS, INC.: PRODUCTS OFFERED 393 TABLE 462 PROMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 394 TABLE 463 PROMED TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 394 TABLE 464 WHITE EAGLE SONIC TECHNOLOGIES, INC.: COMPANY OVERVIEW 396 TABLE 465 SHENZHEN RICSO TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 397 TABLE 466 YOUKEY MEDICAL: COMPANY OVERVIEW 398 TABLE 467 SIUI: COMPANY OVERVIEW 399 TABLE 468 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING: COMPANY OVERVIEW 400 TABLE 469 BUTTERFLY NETWORK, INC.: COMPANY OVERVIEW 401 TABLE 470 ALPINION MEDICAL SYSTEMS: COMPANY OVERVIEW 402 TABLE 471 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW 403 TABLE 472 SHENZHEN LANDWIND INDUSTRY CO., LTD.: COMPANY OVERVIEW 404 TABLE 473 ECHONOUS INC.: COMPANY OVERVIEW 405 TABLE 474 MOBISANTE, INC.: COMPANY OVERVIEW 406 TABLE 475 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 407 TABLE 476 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW 408 TABLE 477 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW 408 TABLE 478 CURA HEALTHCARE: COMPANY OVERVIEW 410 FIGURE 1 ULTRASOUND MARKET SEGMENTATION & REGIONAL SCOPE 33 FIGURE 2 ULTRASOUND MARKET: RESEARCH DATA 37 FIGURE 3 RESEARCH DESIGN 38 FIGURE 4 PRIMARY SOURCES 40 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 42 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42 FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 43 FIGURE 8 ULTRASOUND MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 44 FIGURE 9 ULTRASOUND MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 45 FIGURE 10 TOP-DOWN APPROACH 46 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47 FIGURE 12 DATA TRIANGULATION METHODOLOGY 48 FIGURE 13 ULTRASOUND MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION) 51 FIGURE 14 ULTRASOUND MARKET, BY DISPLAY, 2024 VS. 2030 (USD MILLION) 52 FIGURE 15 ULTRASOUND MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 53 FIGURE 16 ULTRASOUND MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 54 FIGURE 17 GEOGRAPHICAL SNAPSHOT OF ULTRASOUND MARKET 55 FIGURE 18 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 56 FIGURE 19 EUROPE TO DOMINATE DURING FORECAST PERIOD 57 FIGURE 20 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 58 FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59 FIGURE 22 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 23 ULTRASOUND MARKET: VALUE CHAIN ANALYSIS 70 FIGURE 24 ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS 71 FIGURE 25 ULTRASOUND MARKET: PORTER’S FIVE FORCES 72 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 74 FIGURE 27 KEY BUYING CRITERIA, BY END USER 75 FIGURE 28 PATENT ANALYSIS FOR ULTRASOUND MARKET (JANUARY 2013–DECEMBER 2024) 76 FIGURE 29 ULTRASOUND MARKET: ECOSYSTEM ANALYSIS 81 FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85 FIGURE 31 INVESTMENT & FUNDING SCENARIO, 2018–2022 96 FIGURE 32 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 96 FIGURE 33 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION) 97 FIGURE 34 AVERAGE SELLING PRICE OF ULTRASOUND, BY REGION, 2021–2023 (USD) 99 FIGURE 35 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER (2023) 101 FIGURE 36 EUROPE: ULTRASOUND MARKET SNAPSHOT 215   FIGURE 37 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT 259 FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN ULTRASOUND MARKET, 2021–2023 (USD BILLION) 316 FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ULTRASOUND MARKET (2023) 317 FIGURE 40 TOP FIVE COMPANIES COLLECTIVELY ACCOUNT FOR 73–77% MARKET SHARE OF GLOBAL DOPPLER ULTRASOUND MARKET 317 FIGURE 41 RANKING OF KEY PLAYERS IN ULTRASOUND MARKET, 2023 319 FIGURE 42 DIAGNOSTIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 320 FIGURE 43 ULTRASOUND MARKET: COMPANY FOOTPRINT 321 FIGURE 44 THERAPEUTIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 330 FIGURE 45 EV/EBITDA OF KEY VENDORS 332 FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 332 FIGURE 47 ULTRASOUND MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 333 FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 337 FIGURE 49 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023) 344 FIGURE 50 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023) 349 FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 354 FIGURE 52 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023) 359 FIGURE 53 HOLOGIC, INC.: COMPANY SNAPSHOT (2023) 364 FIGURE 54 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023) 369 FIGURE 55 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023) 373 FIGURE 56 NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY SNAPSHOT (2022) 386 FIGURE 57 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2023) 389

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們